Drug Patent Expirations in January 2011

Drug Patent Expirations in January 2011

Drug Patent Expirations in January 2011

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
VITRAVENE PRESERVATIVE FREE Novartis fomivirsen sodium 5,276,019 Jan 4, 2011
ELIGARD Tolmar Therap leuprolide acetate 5,278,201 Jan 11, 2011
ULTIVA Bioniche Teoranta remifentanil hydrochloride 5,019,583*PED Jan 12, 2011
XELODA Hoffmann La Roche capecitabine 4,966,891 Jan 13, 2011
DUETACT Takeda Global glimepiride; pioglitazone hydrochloride 4,687,777 Jan 17, 2011
ACTOS Takeda Pharms Na pioglitazone hydrochloride 4,687,777 Jan 17, 2011
ACTOPLUS MET Takeda Global metformin hydrochloride; pioglitazone hydrochloride 4,687,777 Jan 17, 2011
ACTOPLUS MET XR Takeda Global metformin hydrochloride; pioglitazone hydrochloride 4,687,777 Jan 17, 2011
PROTONIX IV Wyeth Pharms Inc pantoprazole sodium 4,758,579*PED Jan 19, 2011
PROTONIX Wyeth Pharms Inc pantoprazole sodium 4,758,579*PED Jan 19, 2011
EMEND Merck aprepitant 5,145,684 Jan 25, 2011
MEGACE ES Par Pharm megestrol acetate 5,145,684 Jan 25, 2011
TRICOR Abbott fenofibrate 5,145,684 Jan 25, 2011
VFEND Pfizer voriconazole 5,773,443 Jan 25, 2011
BAYCOL Bayer Pharms cerivastatin sodium 5,177,080 Jan 26, 2011

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com

NO COMMENTS

Leave a Reply